Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization

被引:581
作者
Bajou, K
Noël, A
Gerard, RD
Masson, V
Brunner, N
Holst-Hansen, C
Skobe, M
Fusenig, NE
Carmeliet, P
Collen, D
Foidart, JM
机构
[1] Univ Liege, Lab Tumor & Dev Biol, B-4000 Liege, Belgium
[2] Flanders Interuniv Inst Biotechnol, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium
[3] Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark
[4] German Canc Res Ctr, Div Carcinogenesis & Differentiat, D-69120 Heidelberg, Germany
关键词
D O I
10.1038/nm0898-923
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acquisition of invasive/metastatic potential through protease expression is an essential event in tumor progression. High levels of components of the plasminogen activation system, including urokinase, but paradoxically also its inhibitor, plasminogen activator inhibitor 1 (PAI1), have been correlated with a poor prognosis for some cancers. We report here that deficient PAI1 expression in host mice prevented local invasion and tumor vascularization of transplanted malignant keratinocytes. When this PAI1 deficiency was circumvented by intravenous injection of a replication-defective adenoviral vector expressing human PAI1, invasion and associated angiogenesis were restored. This experimental evidence demonstrates that host-produced PAI is essential for cancer cell invasion and angiogenesis.
引用
收藏
页码:923 / 928
页数:6
相关论文
共 43 条
  • [1] Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
  • [2] 2-Z
  • [3] INVIVO PATTERNS OF EXPRESSION OF UROKINASE AND ITS INHIBITOR PAI-1 SUGGEST A CONCERTED ROLE IN REGULATING PHYSIOLOGICAL ANGIOGENESIS
    BACHARACH, E
    ITIN, A
    KESHET, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) : 10686 - 10690
  • [4] IMMUNOHISTOCHEMICAL LOCALIZATION OF THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN BREAST-CANCER
    BIANCHI, E
    COHEN, RL
    DAI, A
    THOR, AT
    SHUMAN, MA
    SMITH, HS
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (05) : 597 - 603
  • [5] UROKINASE AND UROKINASE RECEPTOR - A PARACRINE AUTOCRINE SYSTEM REGULATING CELL-MIGRATION AND INVASIVENESS
    BLASI, F
    [J]. BIOESSAYS, 1993, 15 (02) : 105 - 111
  • [6] BOUKAMP P, 1990, CANCER RES, V50, P2840
  • [7] Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation - A gene targeting and gene transfer study in mice
    Carmeliet, P
    Moons, L
    Lijnen, HR
    Janssens, S
    Lupu, F
    Collen, D
    Gerard, RD
    [J]. CIRCULATION, 1997, 96 (09) : 3180 - 3191
  • [8] Impaired arterial neointima formation in mice with disruption of the plasminogen gene
    Carmeliet, P
    Moons, L
    Ploplis, V
    Plow, E
    Collen, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (02) : 200 - 208
  • [9] PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE DEFICIENT MICE .2. EFFECTS ON HEMOSTASIS, THROMBOSIS, AND THROMBOLYSIS
    CARMELIET, P
    STASSEN, JM
    SCHOONJANS, L
    REAM, B
    VANDENOORD, JJ
    DEMOL, M
    MULLIGAN, RC
    COLLEN, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) : 2756 - 2760
  • [10] PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE DEFICIENT MICE .1. GENERATION BY HOMOLOGOUS RECOMBINATION AND CHARACTERIZATION
    CARMELIET, P
    KIECKENS, L
    SCHOONJANS, L
    REAM, B
    VANNUFFELEN, A
    PRENDERGAST, G
    COLE, M
    BRONSON, R
    COLLEN, D
    MULLIGAN, RC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) : 2746 - 2755